Drs. Barnett and Brujic Discuss the Keratoconus Testing Consensus Statement

This activity is supported by an unrestricted educational grant from Avellino.

Learning Objectives

Upon completion of this activity, the participant should be able to:

• Define etiology and progression of keratoconus, understand how refractive surgery can exacerbate these conditions, and review the impact this has on visual outcomes and quality of life
• Describe the prevalence of the refractive surgery patients developing keratoconus in various patient populations
• Identify the accuracy of various conventional and new genetic testing metrics for identifying refractive surgery patients who may be at risk for developing keratoconus
• Review treatment options for refractive surgery candidates who have or are likely to develop keratoconus
• Recommend diagnostic work-up protocols and pre-emptive testing indications for various groups of refractive surgery patients to maximize the diagnosis of keratoconus suspects

Accreditation and Designation Statement

Sponsored by:

Evolve Medical Education LLC (Evolve) is an approved COPE administrator.
This activity, COPE Activity Number 122174, is accredited by COPE for continuing education for optometrists. 
This course is approved for .25 hours of CE. 
Course #:  73478-AS
Activity ID: 122174

Participation Method

In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS

Hardware Requirements:
4GB+ RAM
Recommended internet speed 5Mbps+

Faculty and Disclosures

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.

The following faculty/staff members have the following financial relationships with commercial interests:

Melissa Barnett, OD, FAAO, FSLS, FBCLA, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Advisory Board: Azura, Bruder, Cooper Vision, Dompe, Everyday Contacts, EyeEco, Mojo Vision, Novartis, Ocusoft, Oyster Point,  Percept, and Raayonnova. Advisory Board/Consultant: Visus Therapeutics. Advisory Board/Speaker's Bureau: AAB, Acculens, Allergan, Bausch + Lomb, Contamac, Gas Permeable Lens Institute, JJVC Vistakon, RVL Pharmaceuticals, Scleral Lense Education Society, Synergeyes, Tangible Science, Tarsus. Speaker's Bureau: BCLA, Science Based Health, Sjogren's Syndrom Foundation, and STAPLE Program.

Mile Brujic, OD, FAAO, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Akorn, Alcon Vision, Allergan, Bausch + Lomb Health, Blephex, Contamac, CSEye, Eyevance, Horizon Therapeutics, Kala Pharmaceuticals, Novartis, Sun Pharmaceutical Industries, VMax Vision, and Zea Vision. Speaker’s Bureau: Allergan, Bausch + Lomb Health, Kala Pharmaceuticals, Novartis, Optovue, Sun Pharmaceutical Industries, and Zea Vision. Grant/Research Support: Contamac.

The Evolve and The Fundingsland Group planners have no financial relationships with commercial interests. 

Disclaimer

OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, The Fundingsland Group or Avellino.